Overview Financials News + Filings Key Docs Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
OPIANT PHARMACEUTICALS, INC. (LLTP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/03/2023 |
4
| Silver Gabrielle Alison (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 21,343 shares
@ $20, valued at
$426.9k
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 2,500 options to buy
@ $15.56, valued at
$38.9k
Disposed/sold 2,500 options to buy
@ $12.75, valued at
$31.9k
Disposed/sold 2,500 options to buy
@ $8.79, valued at
$22k
Disposed/sold 2,500 options to buy
@ $13.3, valued at
$33.3k
|
|
| 03/03/2023 |
4
| Collard Craig A (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 53,822 shares
@ $20, valued at
$1.1M
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 5,000 options to buy
@ $17.61, valued at
$88.1k
Disposed/sold 2,500 options to buy
@ $12.75, valued at
$31.9k
Disposed/sold 2,500 options to buy
@ $8.79, valued at
$22k
Disposed/sold 2,500 options to buy
@ $13.3, valued at
$33.3k
|
|
| 03/03/2023 |
4
| Ruth Matthew R. (Chief Commercial Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 19,250 shares
@ $20, valued at
$385k
Disposed/sold 10,666 shares
@ $20, valued at
$213.3k
Granted 2,000 shares
@ $0
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 50,000 options to buy
@ $16.41, valued at
$820.5k
|
|
| 03/03/2023 |
4
| Daly Richard J (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 5,800 shares
@ $20, valued at
$116k
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 2,500 options to buy
@ $12.75, valued at
$31.9k
Disposed/sold 2,500 options to buy
@ $13.3, valued at
$33.3k
Disposed/sold 5,000 options to buy
@ $15.56, valued at
$77.8k
Disposed/sold 2,500 options to buy
@ $8.79, valued at
$22k
|
|
| 03/03/2023 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 37,438 shares
@ $20, valued at
$748.8k
Disposed/sold 37,901 shares
@ $20, valued at
$758k
Disposed/sold 5,100 shares
@ $20, valued at
$102k
Granted 6,667 shares
@ $0
Disposed/sold 6,667 shares
@ $20, valued at
$133.3k
Disposed/sold 25,000 options
@ $6, valued at
$150k
Disposed/sold 150,000 options
@ $5, valued at
$750k
Disposed/sold 375,000 options
@ $7.25, valued at
$2.7M
Disposed/sold 13,200 options to buy
@ $14.62, valued at
$193k
Disposed/sold 27,250 options to buy
@ $13.6, valued at
$370.6k
Disposed/sold 31,250 options to buy
@ $12.15, valued at
$379.7k
|
|
| 03/03/2023 |
4
| Ellison Mark Jason Heath (Chief Development Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 7,015 shares
@ $20, valued at
$140.3k
Disposed/sold 11,736 shares
@ $20, valued at
$234.7k
Disposed/sold 9,680 shares
@ $20, valued at
$193.6k
Granted 2,000 shares
@ $0
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 7,200 options to buy
@ $13.61, valued at
$98k
Disposed/sold 8,250 options to buy
@ $13.6, valued at
$112.2k
Disposed/sold 10,750 options to buy
@ $12.15, valued at
$130.6k
|
|
| 03/03/2023 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 9,812 shares
@ $20, valued at
$196.2k
Disposed/sold 11,736 shares
@ $20, valued at
$234.7k
Granted 2,000 shares
@ $0
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 40,000 options to buy
@ $9, valued at
$360k
Disposed/sold 13,200 options to buy
@ $13.61, valued at
$179.7k
Disposed/sold 8,250 options to buy
@ $13.6, valued at
$112.2k
Disposed/sold 10,750 options to buy
@ $12.15, valued at
$130.6k
|
|
| 03/03/2023 |
4
| Sinclair Michael (10% Owner) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 27,450 shares
@ $20, valued at
$549k
Disposed/sold 22,720 shares
@ $20, valued at
$454.4k
Disposed/sold 40,000 shares
@ $20, valued at
$800k
Disposed/sold 100,000 options
@ $8, valued at
$800k
Disposed/sold 250,000 options
@ $7.25, valued at
$1.8M
Disposed/sold 75,000 options
@ $6, valued at
$450k
|
|
| 03/03/2023 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 26,179 shares
@ $20, valued at
$523.6k
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 2,500 options to buy
@ $15.56, valued at
$38.9k
Disposed/sold 2,500 options to buy
@ $12.75, valued at
$31.9k
Disposed/sold 2,500 options to buy
@ $8.79, valued at
$22k
Disposed/sold 2,500 options to buy
@ $13.3, valued at
$33.3k
|
|
| 03/03/2023 |
4
| Lorianne Masuoka K. (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 2,000 shares
@ $20, valued at
$40k
Granted 5,000 options to buy
@ $10.8, valued at
$54k
|
|
| 03/03/2023 |
4
| Gorman Brian (General Counsel) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 14,540 shares
@ $20, valued at
$290.8k
Disposed/sold 17,450 shares
@ $20, valued at
$349k
Granted 2,000 shares
@ $0
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 36,500 options to buy
@ $11.3, valued at
$412.5k
Disposed/sold 10,750 options to buy
@ $12.15, valued at
$130.6k
|
|
| 03/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 22,512 shares
@ $20, valued at
$450.2k
Disposed/sold 11,736 shares
@ $20, valued at
$234.7k
Granted 2,000 shares
@ $0
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 33,000 options to buy
@ $13.61, valued at
$449.1k
Disposed/sold 8,250 options to buy
@ $13.6, valued at
$112.2k
Disposed/sold 10,750 options to buy
@ $12.15, valued at
$130.6k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 541 shares
@ $20.26, valued at
$11k
|
|
| 01/09/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 415 shares
@ $20.2, valued at
$8.4k
|
|
| 01/09/2023 |
4
| Ellison Mark Jason Heath (Chief Development Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 469 shares
@ $20.2, valued at
$9.5k
|
|
| 01/09/2023 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 369 shares
@ $20.2, valued at
$7.5k
|
|
| 01/09/2023 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,183 shares
@ $20.2, valued at
$23.9k
|
|
| 01/05/2023 |
4
| Ellison Mark Jason Heath (Chief Development Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,806 shares
@ $20.2, valued at
$36.5k
|
|
| 01/05/2023 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,600 shares
@ $20.2, valued at
$32.3k
|
|
| 01/05/2023 |
4
| Gorman Brian (General Counsel) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,313 shares
@ $20.2, valued at
$26.5k
|
|
| 01/05/2023 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,421 shares
@ $20.2, valued at
$28.7k
|
|
| 01/05/2023 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 5,029 shares
@ $20.2, valued at
$101.6k
|
|
| 07/21/2022 |
4
| Ruth Matthew R. (Chief Commercial Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,084 shares
@ $10.62, valued at
$11.5k
|
|
| 07/15/2022 |
4
| O'Toole David D (CFO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 779 shares
@ $11.1, valued at
$8.6k
|
|
| 07/15/2022 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 627 shares
@ $11.85, valued at
$7.4k
|
|
| 07/15/2022 |
4
| Gorman Brian (General Counsel) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 691 shares
@ $11.16, valued at
$7.7k
|
|
| 07/15/2022 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,246 shares
@ $11.11, valued at
$25k
|
|
| 06/29/2022 |
4
| Ellison Mark Jason Heath (Chief Development Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 2,000 shares
@ $0 |
|
| 06/29/2022 |
4
| CRYSTAL ROGER (CEO) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 6,667 shares
@ $0 |
|
|
|
|